Performance
Total traded value
0.27 CrFundamentals
Market Cap | ₹1,855Cr |
ROE | 21.52% |
P/E Ratio(TTM) | 43.74 |
EPS(TTM) | 42.02 |
P/B Ratio | 9.41 |
Dividend Yield | 0.00% |
Industry P/E | 35.77 |
Book Value | 195.25 |
Debt to Equity | 0.67 |
Face Value | 10 |
Financials
*All values are in Rs. Cr
About Beta Drugs
Beta Drugs Limited is a leading Indian pharmaceutical company dedicated to the oncology segment, specializing in manufacturing and trading cancer-related medicines for the branded market. Its strategy centers on achieving differentiation in the market through a focus on novel drug delivery and innovative formulation development to provide unique healthcare solutions. The company has established itself as a significant player, ranking among the top 10 oncology companies operating within India's competitive pharmaceutical landscape.;
Parent Organisation | Beta Drugs Limited |
Managing Director | Mr. Vijay Batra |
Shareholding Pattern
Sep '24
Nov '24
Dec '24
Mar '25
Jun '25